CCA
AMGN icon

Cypress Capital Advisors’s Amgen AMGN Stock Holding History

Cypress Capital Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Sell
2,970
-171
-5% -$58.5K 0.44% 32
2026
Q1 		$1.11M Sell
3,141
-38
-1% -$13.5K 0.6% 27
2025
Q4 		$1.04M Sell
3,179
-24
-0.7% -$7.61K 0.56% 30
2025
Q3 		$904K Sell
3,203
-213
-6% -$61.8K 0.51% 38
2025
Q2 		$954K Buy
3,416
+34
+1% +$9.63K 0.6% 32
2025
Q1 		$1.05M Buy
3,382
+61
+2% +$18K 0.73% 27
2024
Q4 		$866K Buy
+3,321
New +$985K 0.68% 34

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Cypress Capital Advisors's AMGN Position: Q2 2026 in Review

Cypress Capital Advisors reduced its Amgen (AMGN) stake by 5.4% in Q2 2026, selling an estimated $58.5K and leaving 2,970 shares worth $1.08M. The position accounts for 0.44% of the portfolio, ranked #32.

Cypress Capital Advisors first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.11M in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cypress Capital Advisors held 2,970 shares of Amgen worth $1.08M as of Q2 2026.
  • Cypress Capital Advisors sold 171 Amgen shares in Q2 2026, an estimated $58.5K.
  • Amgen made up 0.44% of Cypress Capital Advisors's portfolio in Q2 2026, its #32 holding.
  • Cypress Capital Advisors first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • Cypress Capital Advisors's Amgen position peaked at $1.11M in Q1 2026.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cypress Capital Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.